Beijing Beilu Pharmaceutical - Asset Resilience Ratio

Latest as of September 2025: 10.67%

Beijing Beilu Pharmaceutical (300016) has an Asset Resilience Ratio of 10.67% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Beijing Beilu Pharmaceutical current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥343.64 Million

≈ $50.28 Million USD Cash + Short-term Investments

Total Assets

CN¥3.22 Billion

≈ $471.45 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2024)

This chart shows how Beijing Beilu Pharmaceutical's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Beijing Beilu Pharmaceutical balance sheet assets.

Liquid Assets Composition Over Time

This chart breaks down Beijing Beilu Pharmaceutical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore 300016 long-term investments to assets to see how much of total assets are deployed in long-term investments.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥343.64 Million	10.67%
Total Liquid Assets	CN¥343.64 Million	10.67%

Asset Resilience Insights

Moderate Liquidity: Beijing Beilu Pharmaceutical has 10.67% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Beijing Beilu Pharmaceutical Industry Peers by Asset Resilience Ratio

Compare Beijing Beilu Pharmaceutical's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ) ST:SOBI	Drug Manufacturers - Specialty & Generic	1.54%
Yunnan Baiyao Group Co Ltd SHE:000538	Drug Manufacturers - Specialty & Generic	8.38%
Guangdong Zhongsheng Pharmaceutical Co Ltd SHE:002317	Drug Manufacturers - Specialty & Generic	6.62%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Harbin Gloria Pharmaceuticals SHE:002437	Drug Manufacturers - Specialty & Generic	9.04%
Jiuzhitang Co Ltd SHE:000989	Drug Manufacturers - Specialty & Generic	7.86%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	Drug Manufacturers - Specialty & Generic	0.29%

Annual Asset Resilience Ratio for Beijing Beilu Pharmaceutical (2005–2024)

The table below shows the annual Asset Resilience Ratio data for Beijing Beilu Pharmaceutical.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	11.78%	CN¥350.77 Million ≈ $51.33 Million	CN¥2.98 Billion ≈ $435.71 Million	+12.39pp
2023-12-31	-0.61%	CN¥-17.20 Million ≈ $-2.52 Million	CN¥2.82 Billion ≈ $412.57 Million	-0.08pp
2022-12-31	-0.53%	CN¥-14.79 Million ≈ $-2.16 Million	CN¥2.82 Billion ≈ $412.00 Million	-0.15pp
2021-12-31	-0.38%	CN¥-11.00 Million ≈ $-1.61 Million	CN¥2.90 Billion ≈ $424.78 Million	-0.13pp
2020-12-31	-0.25%	CN¥-7.14 Million ≈ $-1.04 Million	CN¥2.85 Billion ≈ $416.69 Million	+0.21pp
2019-12-31	-0.46%	CN¥-7.47 Million ≈ $-1.09 Million	CN¥1.62 Billion ≈ $237.62 Million	-0.41pp
2018-12-31	-0.05%	CN¥-666.64K ≈ $-97.55K	CN¥1.29 Billion ≈ $188.58 Million	-5.80pp
2016-12-31	5.75%	CN¥55.00 Million ≈ $8.05 Million	CN¥956.09 Million ≈ $139.91 Million	+4.63pp
2005-12-31	1.13%	CN¥1.21 Million ≈ $177.06K	CN¥107.46 Million ≈ $15.72 Million	--

pp = percentage points

About Beijing Beilu Pharmaceutical

SHE:300016 China Drug Manufacturers - Specialty & Generic

Market Cap

$683.64 Million

CN¥4.67 Billion CNY

Market Cap Rank

#10778 Global

#2960 in China

Share Price

CN¥8.30

Change (1 day)

+2.60%

52-Week Range

CN¥7.23 - CN¥11.19

All Time High

CN¥27.25